Laser technology developer JenLab GmbH has received the 2017 Most Innovative Medical Diagnostics Systems Europe Award from Capital Finance International (CFI.co) for its femtosecond laser. Recipient of the 2017 Most Innovative Medical Diagnostics Systems Europe Award. Courtesy of JenLab. The technology provides optical biopsies at a high resolution and can highlight details as small as a single cancer cell. The technology has now also found use as a tool for the testing of anti-aging drugs. Femtosecond lasers can be focused on elastin and collagen while gauging the skin’s condition. Cosmetics companies such as Chanel, L’Oréal and Shiseido now employ JenLab’s technology in their research labs. At hospitals, surgeons employ femtosecond lasers for the precise mapping of brain tumors to remove only the cancerous cells, thus minimizing damage to adjacent healthy cells. JenLab is currently working on a new generation of femtosecond laser devices that will have a significantly smaller footprint whilst maintaining the high resolution. The new version is also expected to be cheaper, allowing smaller hospitals access to the technology. Partnering with medical professionals, JenLab is continuously discovering new uses for the femtosecond laser. Capital Finance International is a print journal and online resource reporting on business, economics and finance. JenLab provides femtosecond laser technology for medicine, biotechnology and cell biology.